OUR CLINICAL TRIALS

  • Status

  • Scenario

  • Patients population

  • Phase

  • Solti Program

  • Sites

  • Search

  • Reset


SOLTI-2508 REWIND
A framework-study for conducting REal-World Evidence (RWE) INvestigation in breast cancer Disease Leer mas
SU2C (BKM120)
A phase II trial of BKM120 (a PI3K inhibitor) in patients with triple negative metastatic Leer mas
TATEN
Targeting non-Luminal disease by PAM50 with pembrolizumab + paclitaxel in Hormone Receptor-positive/HER2-negative advanced/metastatic breast cancer, Leer mas
TILS-001
Treatment of advanced breast cancer with adoptive therapy of CD3+/PD1+ tumor infiltrating lymphocytes. Leer mas
TOT-HER3
A window-of-opportunity study of U3-1402, a HER3-targeting antibody-drug conjugate in operable breast cancer according to Leer mas
TREAT
Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA) Leer mas
ULTIMATE
A Phase II Trial Testing Durvalumab Combined With Endocrine Therapy in Patients With ER+/Her2- Breast Leer mas
SOLTI-2103 VALENTINE
A phase 2 trial of neoadjuVAnt muLti-agENT chemotherapy or patritumab deruxtecan (HER3-DXd; U3-1402 with or Leer mas
PROVA
Phase 0 multicenter, window of opportunity, three-arm, randomized clinical trial of oral metronomic vinorelbine and Leer mas